Related Experiment Videos
P53 mutations in carcinoma breast--a clinicopathological study
1Department of Surgery, Pakistan Institute of Medical Sciences, Islamabad.
JPMA. the Journal of the Pakistan Medical Association
|July 31, 2001
Summary
p53 mutations were found in 13.5% of Pakistani women with breast cancer. However, these p53 mutations did not correlate with tumor aggressiveness, including size, nodal status, or histopathology.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast carcinoma is a significant health concern globally.
- The p53 tumor suppressor gene plays a critical role in preventing cancer development.
- Understanding p53 mutation status can offer insights into breast cancer behavior.
Purpose of the Study:
- To determine the incidence of p53 mutations in female breast carcinoma patients in Pakistan.
- To investigate the potential correlation between p53 mutations and clinicopathological features of breast cancer.
Main Methods:
- A prospective study involving 74 operable breast carcinoma patients undergoing mastectomy.
- Analysis of tumor tissue and peripheral blood for p53 mutations.
- Assessment of clinicopathological parameters: age, tumor size, nodal status, and histopathology.
Main Results:
- p53 mutations were detected in 13.5% of the study cohort.
- No statistically significant correlation was found between p53 mutations and tumor size, nodal status, or histopathological diagnosis.
- Intraductal carcinoma was the most frequent histological variant observed.
Conclusions:
- p53 mutations are present in the breast carcinoma cases from the Pakistani population studied.
- The study did not find a significant association between p53 mutations and indicators of tumor aggressiveness.
- Further research may be warranted to explore other factors influencing breast cancer progression in this population.